Volker Wedershoven
Directeur Général chez ImevaX GmbH
Postes actifs de Volker Wedershoven
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
ImevaX GmbH
 ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Directeur Général | - | - |
Historique de carrière de Volker Wedershoven
Anciens postes connus de Volker Wedershoven
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Directeur/Membre du Conseil | - | 24/10/2022 |
Formation de Volker Wedershoven
| Ludwig-Maximilians-Universität München | Masters Business Admin |
Statistiques
Internationale
| Allemagne | 3 |
| Norvège | 2 |
Opérationnelle
| Chief Executive Officer | 1 |
| Masters Business Admin | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| Entreprise privées | 1 |
|---|---|
ImevaX GmbH
ImevaX GmbH BiotechnologyHealth Technology ImevaX GmbH develops vaccines against pathogens of chronic infectious diseases, especially helicobacter pylori. It offers diagnostic and therapeutic methods for bacterial agents. The company was founded by Markus Gerhard in 2014 and is headquartered in Munich, Germany. | Health Technology |
- Bourse
- Insiders
- Volker Wedershoven
- Expérience
